{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T16:33:31Z","timestamp":1777566811857,"version":"3.51.4"},"reference-count":77,"publisher":"Elsevier","isbn-type":[{"value":"9780443134555","type":"print"}],"license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["ACI-1548562"],"award-info":[{"award-number":["ACI-1548562"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["M2874"],"award-info":[{"award-number":["M2874"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["2121063"],"award-info":[{"award-number":["2121063"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01GM132572"],"award-info":[{"award-number":["R01GM132572"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006132","name":"Office of Science","doi-asserted-by":"publisher","award":["DE-AC02-05CH11231"],"award-info":[{"award-number":["DE-AC02-05CH11231"]}],"id":[{"id":"10.13039\/100006132","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007859","name":"University of Kansas","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007859","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023]]},"DOI":"10.1016\/bs.vh.2023.05.005","type":"book-chapter","created":{"date-parts":[[2023,6,26]],"date-time":"2023-06-26T18:51:34Z","timestamp":1687805494000},"page":"645-662","source":"Crossref","is-referenced-by-count":2,"title":["Structural dynamics of chemokine receptors"],"prefix":"10.1016","author":[{"given":"Shristi","family":"Pawnikar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sana","family":"Akhter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yinglong","family":"Miao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/bs.vh.2023.05.005_bb0010","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.3390\/ijms19051477","article-title":"Inhibition of the CCL5\/CCR5 axis against the progression of gastric cancer","volume":"19","author":"Aldinucci","year":"2018","journal-title":"International Journal of Molecular Sciences"},{"issue":"2","key":"10.1016\/bs.vh.2023.05.005_bb0015","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1097\/COH.0b013e328324bbec","article-title":"The biology of CCR5 and CXCR4","volume":"4","author":"Alkhatib","year":"2009","journal-title":"Current Opinion in HIV and AIDS"},{"issue":"21","key":"10.1016\/bs.vh.2023.05.005_bb0020","doi-asserted-by":"crossref","first-page":"8555","DOI":"10.1073\/pnas.0903545106","article-title":"Conserved waters mediate structural and functional activation of family a (rhodopsin-like) G protein-coupled receptors","volume":"106","author":"Angel","year":"2009","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"10","key":"10.1016\/bs.vh.2023.05.005_bb0025","doi-asserted-by":"crossref","first-page":"5698","DOI":"10.1073\/pnas.96.10.5698","article-title":"A small-molecule, nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activity","volume":"96","author":"Baba","year":"1999","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"5","key":"10.1016\/bs.vh.2023.05.005_bb0030","doi-asserted-by":"crossref","first-page":"3378","DOI":"10.1074\/jbc.M210140200","article-title":"Ligand-independent dimerization of CXCR4, a principal HIV-1 coreceptor","volume":"278","author":"Babcock","year":"2003","journal-title":"Journal of Biological Chemistry"},{"issue":"1","key":"10.1016\/bs.vh.2023.05.005_bb0035","first-page":"71P","article-title":"Update on the extended family of chemokine receptors and introducing a new nomenclature for atypical chemokine receptors","volume":"66","author":"Bachelerie","year":"2013","journal-title":"Pharmacological Reviews"},{"issue":"1","key":"10.1016\/bs.vh.2023.05.005_bb0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/pr.113.007724","article-title":"International Union of Basic and Clinical Pharmacology. LXXXIX. Update on the extended family of chemokine receptors and introducing a new nomenclature for atypical chemokine receptors","volume":"66","author":"Bachelerie","year":"2014","journal-title":"Pharmacological Reviews"},{"issue":"44","key":"10.1016\/bs.vh.2023.05.005_bb0045","doi-asserted-by":"crossref","first-page":"24332","DOI":"10.1039\/C4CP03331K","article-title":"Computational study on the interaction between CCR5 and HIV-1 entry inhibitor maraviroc: Insight from accelerated molecular dynamics simulation and free energy calculation","volume":"16","author":"Bai","year":"2014","journal-title":"Physical Chemistry Chemical Physics"},{"issue":"3","key":"10.1016\/bs.vh.2023.05.005_bb0050","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.semcancer.2003.10.003","article-title":"The significance of cancer cell expression of the chemokine receptor CXCR4","volume":"14","author":"Balkwill","year":"2004","journal-title":"Seminars in Cancer Biology"},{"issue":"1","key":"10.1016\/bs.vh.2023.05.005_bb0055","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1146\/annurev.immunol.17.1.657","article-title":"Chemokine receptors as HIV-1 coreceptors: Roles in viral entry, tropism, and disease","volume":"17","author":"Berger","year":"1999","journal-title":"Annual Review of Immunology"},{"issue":"6","key":"10.1016\/bs.vh.2023.05.005_bb0060","first-page":"1899","article-title":"CCR5 binds multiple CC-chemokines: MCP-3 acts as a natural antagonist","volume":"94","author":"Blanpain","year":"1999","journal-title":"Blood, The Journal of the American Society of Hematology"},{"issue":"31","key":"10.1016\/bs.vh.2023.05.005_bb0065","doi-asserted-by":"crossref","first-page":"23736","DOI":"10.1074\/jbc.M000776200","article-title":"Identification of residues of CXCR4 critical for human immunodeficiency virus coreceptor and chemokine receptor activities","volume":"275","author":"Brelot","year":"2000","journal-title":"Journal of Biological Chemistry"},{"issue":"6226","key":"10.1016\/bs.vh.2023.05.005_bb0070","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1126\/science.aaa5026","article-title":"Structural basis for chemokine recognition and activation of a viral G protein\u2013coupled receptor","volume":"347","author":"Burg","year":"2015","journal-title":"Science"},{"issue":"8","key":"10.1016\/bs.vh.2023.05.005_bb0075","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1038\/s41587-020-0602-4","article-title":"COVID-19 severity correlates with airway epithelium\u2013immune cell interactions identified by single-cell analysis","volume":"38","author":"Chua","year":"2020","journal-title":"Nature Biotechnology"},{"issue":"5243","key":"10.1016\/bs.vh.2023.05.005_bb0080","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1126\/science.270.5243.1811","article-title":"Identification of RANTES, MIP-1\u03b1, and MIP-1\u03b2 as the major HIV-suppressive factors produced by CD8+ T cells","volume":"270","author":"Cocchi","year":"1995","journal-title":"Science"},{"issue":"23","key":"10.1016\/bs.vh.2023.05.005_bb0085","doi-asserted-by":"crossref","first-page":"9475","DOI":"10.1073\/pnas.1222205110","article-title":"HIV-1 exploits CCR5 conformational heterogeneity to escape inhibition by chemokines","volume":"110","author":"Colin","year":"2013","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"9","key":"10.1016\/bs.vh.2023.05.005_bb0090","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/nrd4308","article-title":"Opportunities and challenges in the discovery of allosteric modulators of GPCRs for treating CNS disorders","volume":"13","author":"Conn","year":"2014","journal-title":"Nature Reviews Drug Discovery"},{"issue":"4","key":"10.1016\/bs.vh.2023.05.005_bb0095","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1084\/jem.185.4.621","article-title":"Change in coreceptor use correlates with disease progression in HIV-1\u2013infected individuals","volume":"185","author":"Connor","year":"1997","journal-title":"The Journal of Experimental Medicine"},{"issue":"4","key":"10.1016\/bs.vh.2023.05.005_bb0100","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.1128\/JVI.73.4.2752-2761.1999","article-title":"Identification of CXCR4 domains that support coreceptor and chemokine receptor functions","volume":"73","author":"Doranz","year":"1999","journal-title":"Journal of Virology"},{"issue":"9","key":"10.1016\/bs.vh.2023.05.005_bb0105","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.bcp.2013.08.019","article-title":"Allosteric peptide regulators of chemokine receptors CXCR4 and CXCR7","volume":"86","author":"Ehrlich","year":"2013","journal-title":"Biochemical Pharmacology"},{"issue":"7","key":"10.1016\/bs.vh.2023.05.005_bb0110","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s10822-006-9064-0","article-title":"Inactive and active states and supramolecular organization of GPCRs: Insights from computational modeling","volume":"20","author":"Fanelli","year":"2006","journal-title":"Journal of Computer-Aided Molecular Design"},{"issue":"3","key":"10.1016\/bs.vh.2023.05.005_bb0115","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1021\/ci050490k","article-title":"Modeling the structural basis of human CCR5 chemokine receptor function: From homology model building and molecular dynamics validation to agonist and antagonist docking","volume":"46","author":"Fano","year":"2006","journal-title":"Journal of Chemical Information and Modeling"},{"issue":"4","key":"10.1016\/bs.vh.2023.05.005_bb0120","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1159\/000354132","article-title":"Physiology and pharmacology of plerixafor","volume":"40","author":"Fricker","year":"2013","journal-title":"Transfusion Medicine and Hemotherapy"},{"issue":"38","key":"10.1016\/bs.vh.2023.05.005_bb0125","doi-asserted-by":"crossref","first-page":"33409","DOI":"10.1074\/jbc.M111.279596","article-title":"Allosteric model of maraviroc binding to CC chemokine receptor 5 (CCR5)","volume":"286","author":"Garcia-Perez","year":"2011","journal-title":"Journal of Biological Chemistry"},{"issue":"2","key":"10.1016\/bs.vh.2023.05.005_bb0130","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/84209","article-title":"Chemokines and disease","volume":"2","author":"Gerard","year":"2001","journal-title":"Nature Immunology"},{"issue":"16","key":"10.1016\/bs.vh.2023.05.005_bb0135","doi-asserted-by":"crossref","first-page":"13217","DOI":"10.1074\/jbc.M011670200","article-title":"The TXP motif in the second transmembrane helix of CCR5: A structural determinant of chemokine-induced activation","volume":"276","author":"Govaerts","year":"2001","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/bs.vh.2023.05.005_bb0140","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.ejmech.2017.08.027","article-title":"An update on small molecules targeting CXCR4 as starting points for the development of anti-cancer therapeutics","volume":"139","author":"Grande","year":"2017","journal-title":"European Journal of Medicinal Chemistry"},{"issue":"598","key":"10.1016\/bs.vh.2023.05.005_bb0145","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aaw3657","article-title":"Kinetics of CXCL12 binding to atypical chemokine receptor 3 reveal a role for the receptor N terminus in chemokine binding","volume":"12","author":"Gustavsson","year":"2019","journal-title":"Science Signaling"},{"issue":"7","key":"10.1016\/bs.vh.2023.05.005_bb0150","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1038\/nsmb.1456","article-title":"Viral membrane fusion","volume":"15","author":"Harrison","year":"2008","journal-title":"Nature Structural & Molecular Biology"},{"issue":"7","key":"10.1016\/bs.vh.2023.05.005_bb0155","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0960-9822(98)70155-1","article-title":"Dissociation of the signalling and antiviral properties of SDF-1-derived small peptides","volume":"8","author":"Heveker","year":"1998","journal-title":"Current Biology"},{"issue":"4","key":"10.1016\/bs.vh.2023.05.005_bb0160","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S1046-2023(02)00361-4","article-title":"Development and evaluation of pharmacological agents targeting chemokine receptors","volume":"29","author":"Horuk","year":"2003","journal-title":"Methods"},{"issue":"25","key":"10.1016\/bs.vh.2023.05.005_bb0165","first-page":"eabg8685","article-title":"Structural basis of the activation of the CC chemokine receptor 5 by a chemokine agonist. Science","volume":"7","author":"Isaikina","year":"2021","journal-title":"Advances"},{"issue":"27","key":"10.1016\/bs.vh.2023.05.005_bb0170","doi-asserted-by":"crossref","first-page":"19042","DOI":"10.1074\/jbc.M114.559831","article-title":"Targeting spare CC chemokine receptor 5 (CCR5) as a principle to inhibit HIV-1 entry","volume":"289","author":"Jin","year":"2014","journal-title":"Journal of Biological Chemistry"},{"issue":"6165","key":"10.1016\/bs.vh.2023.05.005_bb0175","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1126\/science.1245625","article-title":"Crystal structure of a soluble cleaved HIV-1 envelope trimer","volume":"342","author":"Julien","year":"2013","journal-title":"Science"},{"issue":"1","key":"10.1016\/bs.vh.2023.05.005_bb0180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pharmthera.2011.06.008","article-title":"Targeting chemokine receptors in chronic inflammatory diseases: An extensive review","volume":"133","author":"Koelink","year":"2012","journal-title":"Pharmacology & Therapeutics"},{"issue":"50","key":"10.1016\/bs.vh.2023.05.005_bb0185","doi-asserted-by":"crossref","first-page":"35240","DOI":"10.1074\/jbc.M109.024851","article-title":"Structural basis of the interaction between chemokine stromal cell-derived factor-1\/CXCL12 and its G-protein-coupled receptor CXCR4","volume":"284","author":"Kofuku","year":"2009","journal-title":"Journal of Biological Chemistry"},{"issue":"6686","key":"10.1016\/bs.vh.2023.05.005_bb0190","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/31405","article-title":"Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody","volume":"393","author":"Kwong","year":"1998","journal-title":"Nature"},{"issue":"6","key":"10.1016\/bs.vh.2023.05.005_bb0195","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1124\/mol.104.009779","article-title":"Mutation of the DRY motif reveals different structural requirements for the CC chemokine receptor 5-mediated signaling and receptor endocytosis","volume":"67","author":"Lagane","year":"2005","journal-title":"Molecular Pharmacology"},{"issue":"1","key":"10.1016\/bs.vh.2023.05.005_bb0200","first-page":"34","article-title":"CXCR4 dimerization and \u03b2-arrestin\u2013mediated signaling account for the enhanced chemotaxis to CXCL12 in WHIM syndrome","volume":"112","author":"Lagane","year":"2008","journal-title":"Blood, The Journal of the American Society of Hematology"},{"issue":"4","key":"10.1016\/bs.vh.2023.05.005_bb0205","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/nrd2518","article-title":"Structural diversity of G protein-coupled receptors and significance for drug discovery","volume":"7","author":"Lagerstr\u00f6m","year":"2008","journal-title":"Nature Reviews Drug Discovery"},{"issue":"5846","key":"10.1016\/bs.vh.2023.05.005_bb0210","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1126\/science.1145373","article-title":"Structures of the CCR5 N terminus and of a tyrosine-sulfated antibody with HIV-1 gp120 and CD4","volume":"317","author":"Huang","year":"2007","journal-title":"Science"},{"issue":"6277","key":"10.1016\/bs.vh.2023.05.005_bb0215","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1126\/science.aad2450","article-title":"Cryo-EM structure of a native, fully glycosylated, cleaved HIV-1 envelope trimer","volume":"351","author":"Lee","year":"2016","journal-title":"Science"},{"issue":"35","key":"10.1016\/bs.vh.2023.05.005_bb0220","doi-asserted-by":"crossref","first-page":"22279","DOI":"10.1074\/jbc.273.35.22279","article-title":"N-terminal peptides of stromal cell-derived factor-1 with CXC chemokine receptor 4 agonist and antagonist activities","volume":"273","author":"Loetscher","year":"1998","journal-title":"Journal of Biological Chemistry"},{"issue":"2","key":"10.1016\/bs.vh.2023.05.005_bb0225","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/nrneurol.2015.248","article-title":"CCR5 blockade for neuroinflammatory diseases\u2014Beyond control of HIV","volume":"12","author":"Martin-Blondel","year":"2016","journal-title":"Nature Reviews Neurology"},{"issue":"4","key":"10.1016\/bs.vh.2023.05.005_bb0230","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3000656","article-title":"Crosslinking-guided geometry of a complete CXC receptor-chemokine complex and the basis of chemokine subfamily selectivity","volume":"18","author":"Ngo","year":"2020","journal-title":"PLoS Biology"},{"issue":"3","key":"10.1016\/bs.vh.2023.05.005_bb0235","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1073\/pnas.0911004107","article-title":"Structure of HIV-1 gp120 with gp41-interactive region reveals layered envelope architecture and basis of conformational mobility","volume":"107","author":"Pancera","year":"2010","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"7523","key":"10.1016\/bs.vh.2023.05.005_bb0240","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/nature13808","article-title":"Structure and immune recognition of trimeric pre-fusion HIV-1 Env","volume":"514","author":"Pancera","year":"2014","journal-title":"Nature"},{"key":"10.1016\/bs.vh.2023.05.005_bb0245","article-title":"Disruption of the CCL5\/RANTES-CCR5 pathway restores immune homeostasis and reduces plasma viral load in critical COVID-19","author":"Patterson","year":"2020","journal-title":"MedRxiv"},{"issue":"13","key":"10.1016\/bs.vh.2023.05.005_bb0250","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.4155\/fmc-2020-0044","article-title":"Pathway and mechanism of drug binding to chemokine receptors revealed by accelerated molecular simulations","volume":"12","author":"Pawnikar","year":"2020","journal-title":"Future Medicinal Chemistry"},{"key":"10.1016\/bs.vh.2023.05.005_bb0255","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2022.821055","article-title":"Mechanism of peptide agonist binding in CXCR4 chemokine receptor","volume":"9","author":"Pawnikar","year":"2022","journal-title":"Frontiers in Molecular Biosciences"},{"issue":"11","key":"10.1016\/bs.vh.2023.05.005_bb0260","doi-asserted-by":"crossref","first-page":"9895","DOI":"10.1074\/jbc.M411151200","article-title":"Bioluminescence resonance energy transfer reveals ligand-induced conformational changes in CXCR4 homo-and heterodimers","volume":"280","author":"Percherancier","year":"2005","journal-title":"Journal of Biological Chemistry"},{"issue":"6226","key":"10.1016\/bs.vh.2023.05.005_bb0265","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1126\/science.1261064","article-title":"Crystal structure of the chemokine receptor CXCR4 in complex with a viral chemokine","volume":"347","author":"Qin","year":"2015","journal-title":"Science"},{"issue":"29","key":"10.1016\/bs.vh.2023.05.005_bb0270","doi-asserted-by":"crossref","first-page":"30000","DOI":"10.1074\/jbc.M313883200","article-title":"Ligand selectivity and affinity of chemokine receptor CXCR1: Role of N-terminal domain","volume":"279","author":"Rajagopalan","year":"2004","journal-title":"Journal of Biological Chemistry"},{"issue":"8","key":"10.1016\/bs.vh.2023.05.005_bb0275","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/nrd3478","article-title":"Trends in the exploitation of novel drug targets","volume":"10","author":"Rask-Andersen","year":"2011","journal-title":"Nature Reviews Drug Discovery"},{"issue":"4","key":"10.1016\/bs.vh.2023.05.005_bb0280","doi-asserted-by":"crossref","first-page":"263","DOI":"10.4067\/S0716-97601999000400006","article-title":"Structural biology of chemokine receptors","volume":"32","author":"Rojo","year":"1999","journal-title":"Biological Research"},{"issue":"4","key":"10.1016\/bs.vh.2023.05.005_bb0285","doi-asserted-by":"crossref","first-page":"e281","DOI":"10.1016\/j.ddtec.2012.05.002","article-title":"C (X) CR in silico: Computer-aided prediction of chemokine receptor\u2013ligand interactions","volume":"9","author":"Roumen","year":"2012","journal-title":"Drug Discovery Today: Technologies"},{"issue":"4","key":"10.1016\/bs.vh.2023.05.005_bb0290","doi-asserted-by":"crossref","first-page":"339","DOI":"10.2174\/1568005043340498","article-title":"New advances in HIV entry inhibitors development","volume":"4","author":"Rusconi","year":"2004","journal-title":"Current Drug Targets-Infectious Disorders"},{"issue":"2","key":"10.1016\/bs.vh.2023.05.005_bb0295","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1074\/jbc.M204667200","article-title":"Identification of allosteric peptide agonists of CXCR4","volume":"278","author":"Sachpatzidis","year":"2003","journal-title":"Journal of Biological Chemistry"},{"issue":"8","key":"10.1016\/bs.vh.2023.05.005_bb0300","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1007\/s00018-008-8666-1","article-title":"Modulation of chemokine receptor activity through dimerization and crosstalk","volume":"66","author":"Salanga","year":"2009","journal-title":"Cellular and Molecular Life Sciences"},{"issue":"6","key":"10.1016\/bs.vh.2023.05.005_bb0305","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1111\/j.1476-5381.2011.01551.x","article-title":"Pharmacological modulation of chemokine receptor function","volume":"165","author":"Scholten","year":"2012","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/bs.vh.2023.05.005_bb0310","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.cyto.2018.02.018","article-title":"CCR5: Established paradigms and new frontiers for a \u2018celebrity'chemokine receptor","volume":"109","author":"Scurci","year":"2018","journal-title":"Cytokine"},{"issue":"7739","key":"10.1016\/bs.vh.2023.05.005_bb0315","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/s41586-018-0804-9","article-title":"Structural basis of coreceptor recognition by HIV-1 envelope spike","volume":"565","author":"Shaik","year":"2019","journal-title":"Nature"},{"issue":"18","key":"10.1016\/bs.vh.2023.05.005_bb0320","doi-asserted-by":"crossref","first-page":"12511","DOI":"10.1074\/jbc.M112.449587","article-title":"Biased and constitutive signaling in the CC-chemokine receptor CCR5 by manipulating the interface between transmembrane helices 6 and 7","volume":"288","author":"Steen","year":"2013","journal-title":"Journal of Biological Chemistry"},{"issue":"28","key":"10.1016\/bs.vh.2023.05.005_bb0325","doi-asserted-by":"crossref","first-page":"18263","DOI":"10.1016\/S0021-9258(17)32295-0","article-title":"The N terminus of interleukin-8 (IL-8) receptor confers high affinity binding to human IL-8","volume":"269","author":"Suzuki","year":"1994","journal-title":"Journal of Biological Chemistry"},{"issue":"6152","key":"10.1016\/bs.vh.2023.05.005_bb0330","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1126\/science.1241475","article-title":"Structure of the CCR5 chemokine receptor\u2013HIV entry inhibitor maraviroc complex","volume":"341","author":"Tan","year":"2013","journal-title":"Science"},{"issue":"5750","key":"10.1016\/bs.vh.2023.05.005_bb0335","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1126\/science.1118398","article-title":"Structure of a V3-containing HIV-1 gp120 core","volume":"310","author":"Huang","year":"2005","journal-title":"Science"},{"issue":"11","key":"10.1016\/bs.vh.2023.05.005_bb0340","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1158\/1078-0432.CCR-09-2329","article-title":"CXCL12 (SDF-1)\/CXCR4 pathway in cancer","volume":"16","author":"Teicher","year":"2010","journal-title":"Clinical Cancer Research"},{"issue":"1","key":"10.1016\/bs.vh.2023.05.005_bb0345","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1128\/JVI.72.1.396-404.1998","article-title":"Genetic subtype-independent inhibition of human immunodeficiency virus type 1 replication by CC and CXC chemokines","volume":"72","author":"Trkola","year":"1998","journal-title":"Journal of Virology"},{"issue":"5","key":"10.1016\/bs.vh.2023.05.005_bb0350","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1097\/COH.0b013e328356f6f2","article-title":"Correlation of coreceptor usage and disease progression","volume":"7","author":"Verhofstede","year":"2012","journal-title":"Current Opinion in HIV and AIDS"},{"issue":"10","key":"10.1016\/bs.vh.2023.05.005_bb0355","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1158\/1535-7163.MCT-05-0261","article-title":"Dimerization of CXCR4 in living malignant cells: Control of cell migration by a synthetic peptide that reduces homologous CXCR4 interactions","volume":"5","author":"Wang","year":"2006","journal-title":"Molecular Cancer Therapeutics"},{"issue":"13\u201314","key":"10.1016\/bs.vh.2023.05.005_bb0360","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.drudis.2008.04.004","article-title":"Dimerization of chemokine receptors in living cells: Key to receptor function and novel targets for therapy","volume":"13","author":"Wang","year":"2008","journal-title":"Drug Discovery Today"},{"key":"10.1016\/bs.vh.2023.05.005_bb0365","first-page":"5447","article-title":"Maraviroc: A review of its use in HIV infection and beyond","volume":"9","author":"Woollard","year":"2015","journal-title":"Drug Design, Development and Therapy"},{"issue":"6007","key":"10.1016\/bs.vh.2023.05.005_bb0370","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1126\/science.1194396","article-title":"Structures of the CXCR4 chemokine GPCR with small-molecule and cyclic peptide antagonists","volume":"330","author":"Wu","year":"2010","journal-title":"Science"},{"issue":"1","key":"10.1016\/bs.vh.2023.05.005_bb0375","first-page":"1","article-title":"Structural basis for chemokine recognition and receptor activation of chemokine receptor CCR5","volume":"12","author":"Zhang","year":"2021","journal-title":"Nature Communications"},{"issue":"66","key":"10.1016\/bs.vh.2023.05.005_bb0380","doi-asserted-by":"crossref","first-page":"37855","DOI":"10.1039\/C8RA07686C","article-title":"Using accelerated molecular dynamics simulation to shed light on the mechanism of activation\/deactivation upon mutations for CCR5","volume":"8","author":"Zhang","year":"2018","journal-title":"RSC Advances"},{"issue":"6","key":"10.1016\/bs.vh.2023.05.005_bb0385","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.immuni.2017.05.002","article-title":"Structure of CC chemokine receptor 5 with a potent chemokine antagonist reveals mechanisms of chemokine recognition and molecular mimicry by HIV","volume":"46","author":"Zheng","year":"2017","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/bs.vh.2023.05.005_bb0390","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1006\/abbi.1999.1555","article-title":"Expression and functional characterization of mutant human CXCR4 in insect cells: Role of cysteinyl and negatively charged residues in ligand binding","volume":"373","author":"Zhou","year":"2000","journal-title":"Archives of Biochemistry and Biophysics"}],"container-title":["Vitamins and Hormones","Hormone Receptors: Structures and Functions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0083672923000481?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0083672923000481?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T20:11:52Z","timestamp":1697055112000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0083672923000481"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"ISBN":["9780443134555"],"references-count":77,"URL":"https:\/\/doi.org\/10.1016\/bs.vh.2023.05.005","relation":{},"ISSN":["0083-6729"],"issn-type":[{"value":"0083-6729","type":"print"}],"subject":[],"published":{"date-parts":[[2023]]}}}